Carol Oliveira is a seasoned leader in the pharmaceuticals industry, currently serving as the Head of Analytical Services for External Small Molecules and Oncology at Takeda. With a robust background in quality assurance, Carol excels in managing complex analytical operations, particularly in the realm of...
Carol Oliveira is a seasoned leader in the pharmaceuticals industry, currently serving as the Head of Analytical Services for External Small Molecules and Oncology at Takeda. With a robust background in quality assurance, Carol excels in managing complex analytical operations, particularly in the realm of outsourced commercial and stability testing. Her role involves overseeing a dedicated analytical team and ensuring that all third-party laboratories meet stringent regulatory standards, including those set forth by the U.S. Food and Drug Administration (FDA).
At Takeda, Carol is instrumental in driving key projects that enhance the efficiency and reliability of the OncESSM release and commercial stability program. She is responsible for the analytical budget, where her expertise in program management and financial forecasting plays a critical role in optimizing resource allocation and ensuring that project expenditures align with strategic objectives. Carol’s commitment to quality is evident in her proactive approach to resolving analytical challenges, implementing corrective and preventive actions (CAPA), and ensuring compliance with validation protocols.
Her skills in technology transfer and quality control further bolster her ability to lead initiatives that advance Takeda’s mission of delivering innovative therapies to patients. By fostering a culture of continuous improvement and collaboration, Carol not only enhances operational efficiency but also strengthens the overall quality assurance framework within the organization. Her leadership in these areas positions her as a vital contributor to Takeda's success in the competitive biopharmaceutical landscape.
